Références

Information sur le cancer / Types de cancer / Leucémie myéloïde chronique (LMC) / Traitement / Traitement ciblé

American Cancer Society. (2013, September 23). Leukemia - Chronic Myeloid (Myelogenous). Atlanta, GA. Retrieved 09/30/2014. Extrait de: http://www.cancer.org/acs/groups/cid/documents/webcontent/003112-pdf.pdf.

Cancer Care Ontario. Drug Formulary. Toronto, ON: Cancer Care Ontario.

Health Canada. (2014, May 14). Drugs and Health Products: Summary Basis of Decision (SBD): Bosulif. Ottawa, ON: Health Canada. Extrait de: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/drug-med/sbd_smd_2014_bosulif_152211-eng.php.

Health Canada. (2011, June 30). Drugs and Health Products: Sprycel (dasatinib). Ottawa, ON: Health Canada. Extrait de: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/notices-avis/conditions/sprycel_dhcpl_lapds_104993-eng.php.

Health Canada. (2015, April 2). Drugs and Health Products: Approval of Iclusig with conditions. Ottawa, ON: Health Canada. Extrait de: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/notices-avis/conditions/iclusig_dhcpl_lapds_165121-eng.php.

×
×